fzr Antibodies

Santa Cruz Biotechnology delivers a wide array of fzr Antibodies for studying fzr protein, a crucial regulator in the cell cycle and apoptosis. fzr Antibodies are compatible with multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The fzr protein, also known as Fzr1 or Cdh1, plays a significant role in the anaphase-promoting complex/cyclosome (APC/C) and is essential for the timely progression of the cell cycle. By mediating the degradation of specific cell cycle regulators, fzr ensures proper mitotic exit and prevents premature entry into the next cell cycle phase. Understanding fzr function is vital for elucidating mechanisms of cell division and potential implications in cancer biology. Research has shown that fzr regulation is critical in maintaining genomic stability and preventing uncontrolled cell proliferation. Investigating fzr activity provides insights into cell cycle checkpoints and their role in disease development. Advanced research techniques using monoclonal antibodies enable precise detection and analysis of fzr expression patterns. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cell cycle regulation and cancer biology.